Therese Choquette

Chief Technical Officer at Tigen Pharma SA

Speaker

Therese Choquette is the Chief Technical Officer at Tigen Pharma (Lausanne, Switzerland) She has a long-standing experience in Cell & Gene Therapy, analytical development and CMC; from early development into the commercial space. 2014 she started working at Novartis with the newly transferred CAR-T product (now Kymriah) from University of Pennsylvania and was part of the team taking Kymriah through IND and BLA approval. After leaving Novartis she worked at Janssen with Carvykti, and later at Iovance with Amtagvi before starting at Tigen.

Therese obtained her MSc in Biomedicine and PhD in Rheumatology from the Karolinska Institute in Stockholm, Sweden. She went to UMass Medical School in Worcester (now UMass Chan Medical School), MA, USA for a post-doctoral fellowship in infectious diseases. As a former Licensed Practical Nurse, her passion is to provide high quality cell therapies to patients.